MORLEY, ANDREW,MILLER, REBECCA,LA THANGUE, NICHOLAS
申请号：
CA3056726
公开号：
CA3056726A1
申请日:
2018.03.16
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
The present invention relates to compounds of Formula (I) as defined herein, and salts, hydrates and solvates thereof. The present invention also relates to pharmaceutical compositions comprising compounds of Formula (I), and to the use of compounds of Formula (I) in the treatment or prevention of PRMT5-mediated disorders, such as cancer.
